Skip to main content
Top
Published in: BMC Cancer 1/2001

Open Access 01-12-2001 | Research article

Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study

Authors: Iris D Nagtegaal, Corrie AM Marijnen, Elma Klein Kranenbarg, Adri Mulder-Stapel, Jo Hermans, Cornelis JH van de Velde, J Han JM van Krieken

Published in: BMC Cancer | Issue 1/2001

Login to get access

Abstract

Background

Invasion and metastasis is a complex process governed by the interaction of genetically altered tumor cells and the immunological and inflammatory host reponse. Specific T-cells directed against tumor cells and the nonspecific inflammatory reaction due to tissue damage, cooperate against invasive tumor cells in order to prevent recurrences. Data concerning involvement of individual cell types are readily available but little is known about the coordinate interactions between both forms of immune response.

Patients and methods

The presence of inflammatory infiltrate and eosinophils was determined in 1530 patients with rectal adenocarcinoma from a multicenter trial. We selected 160 patients to analyze this inflammatory infiltrate in more detail using immunohistochemistry. The association with the development of local and distant relapses was determined using univariate and multivariate log rank testing.

Results

Patients with an extensive inflammatory infiltrate around the tumor had lower recurrence rates (3.4% versus 6.9%, p = 0.03), showing the importance of host response against tumor cells. In particular, peritumoral mast cells prevent local and distant recurrence (44% versus 15%, p = 0.007 and 86% versus 21%, p < 0.0001, respectively), with improved survival as a consequence. The presence of intratumoral T-cells had independent prognostic value for the occurrence of distant metastases (32% versus 76%, p < 0.0001).

Conclusions

We showed that next to properties of tumor cells, the amount and type of inflammation is also relevant in the control of rectal cancer. Knowledge of the factors involved may lead to new approaches in the management of rectal cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Caruso RA, Speciale G, Inferrera C: Neutrophil interaction with tumour cells in small early gastric cancer: ultrastructural observations. Histol Histopathol. 1994, 9: 295-303.PubMed Caruso RA, Speciale G, Inferrera C: Neutrophil interaction with tumour cells in small early gastric cancer: ultrastructural observations. Histol Histopathol. 1994, 9: 295-303.PubMed
2.
go back to reference Hakansson L, Adell G, Boeryd B, Sjogren F, Sjodahl R: Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis. Br J Cancer. 1997, 75: 374-380.CrossRefPubMedPubMedCentral Hakansson L, Adell G, Boeryd B, Sjogren F, Sjodahl R: Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis. Br J Cancer. 1997, 75: 374-380.CrossRefPubMedPubMedCentral
3.
go back to reference Reynolds JL, Akhter J, Adams WJ, Morris DL: Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?. Eur J Surg Oncol. 1997, 23: 224-227.CrossRefPubMed Reynolds JL, Akhter J, Adams WJ, Morris DL: Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?. Eur J Surg Oncol. 1997, 23: 224-227.CrossRefPubMed
4.
go back to reference Meiniger CJ: Mast cells and tumor-associated angiogenesis. Chem Immunol. 1995, 62: 239-257.CrossRef Meiniger CJ: Mast cells and tumor-associated angiogenesis. Chem Immunol. 1995, 62: 239-257.CrossRef
5.
go back to reference Dabbous MK, North SM, Haney L, Tipton DA, Nicolson GL: Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis. 1995, 13: 33-41.CrossRefPubMed Dabbous MK, North SM, Haney L, Tipton DA, Nicolson GL: Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts. Clin Exp Metastasis. 1995, 13: 33-41.CrossRefPubMed
6.
go back to reference Dimitriadou V, Koutsilieris M: Mast cell - tumor cell interactions: for or against tumour growth and metastasis ?. Anticancer Res. 1997, 17: 1541-1550.PubMed Dimitriadou V, Koutsilieris M: Mast cell - tumor cell interactions: for or against tumour growth and metastasis ?. Anticancer Res. 1997, 17: 1541-1550.PubMed
7.
go back to reference Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, et al: High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999, 154: 1805-1813.CrossRefPubMedPubMedCentral Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, et al: High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol. 1999, 154: 1805-1813.CrossRefPubMedPubMedCentral
8.
go back to reference Goedegebuure PS, Eberlein TJ: The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol Res. 1995, 14: 119-131.CrossRefPubMed Goedegebuure PS, Eberlein TJ: The role of CD4+ tumor-infiltrating lymphocytes in human solid tumors. Immunol Res. 1995, 14: 119-131.CrossRefPubMed
9.
go back to reference Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997, 182: 318-324. 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6.CrossRefPubMed Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM: Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997, 182: 318-324. 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6.CrossRefPubMed
10.
go back to reference Espi A, Arenas J, Garcia-Granero E, Marti E, Lledo S: Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis Colon Rectum. 1996, 39: 429-434.CrossRefPubMed Espi A, Arenas J, Garcia-Granero E, Marti E, Lledo S: Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis Colon Rectum. 1996, 39: 429-434.CrossRefPubMed
11.
go back to reference Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, et al: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997, 79: 2320-2328. 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P.CrossRefPubMed Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, et al: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997, 79: 2320-2328. 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P.CrossRefPubMed
12.
go back to reference Skinner JM, Jarvis LR, Whitehead R: The cellular response to human colonic neoplasms: macrophage numbers. J Pathol. 1983, 139: 97-103.CrossRefPubMed Skinner JM, Jarvis LR, Whitehead R: The cellular response to human colonic neoplasms: macrophage numbers. J Pathol. 1983, 139: 97-103.CrossRefPubMed
13.
go back to reference Higgins CA, Hatton WJ, McKerr G, Harvey D, Carson J, Hannigan BM: Macrophages and apoptotic cells in human colorectal tumours. Biologicals. 1996, 24: 329-332. 10.1006/biol.1996.0046.CrossRefPubMed Higgins CA, Hatton WJ, McKerr G, Harvey D, Carson J, Hannigan BM: Macrophages and apoptotic cells in human colorectal tumours. Biologicals. 1996, 24: 329-332. 10.1006/biol.1996.0046.CrossRefPubMed
14.
go back to reference Cameron DJ, O'Brien P: Cytotoxicity of cancer patient's macrophages for tumor cells. Cancer. 1982, 50: 498-502.CrossRefPubMed Cameron DJ, O'Brien P: Cytotoxicity of cancer patient's macrophages for tumor cells. Cancer. 1982, 50: 498-502.CrossRefPubMed
15.
go back to reference Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M: Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum. 1995, 38: 290-293.CrossRefPubMed Lachter J, Stein M, Lichtig C, Eidelman S, Munichor M: Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum. 1995, 38: 290-293.CrossRefPubMed
16.
go back to reference Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B: Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol. 1989, 20: 159-163.CrossRefPubMed Fisher ER, Paik SM, Rockette H, Jones J, Caplan R, Fisher B: Prognostic significance of eosinophils and mast cells in rectal cancer. Hum Pathol. 1989, 20: 159-163.CrossRefPubMed
17.
go back to reference Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brünner N, Moesgaard F, et al: Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol. 1999, 189: 487-495. 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I.CrossRefPubMed Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brünner N, Moesgaard F, et al: Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol. 1999, 189: 487-495. 10.1002/(SICI)1096-9896(199912)189:4<487::AID-PATH484>3.0.CO;2-I.CrossRefPubMed
18.
go back to reference Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG, et al: Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer research. 1983, 43: 2997-3000.PubMed Pretlow TP, Keith EF, Cryar AK, Bartolucci AA, Pitts AM, Pretlow TG, et al: Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer research. 1983, 43: 2997-3000.PubMed
19.
go back to reference Satomi A, Murakami S, Ishida K, Hashimoto T, Sonoda M: Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol. 1995, 34: 69-73.CrossRefPubMed Satomi A, Murakami S, Ishida K, Hashimoto T, Sonoda M: Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol. 1995, 34: 69-73.CrossRefPubMed
20.
go back to reference Jass JR, Love SB, Northover JMA: A new prognostic classification of rectal cancer. Lancet. 1987, 1: 1303-1306. 10.1016/S0140-6736(87)90552-6.CrossRefPubMed Jass JR, Love SB, Northover JMA: A new prognostic classification of rectal cancer. Lancet. 1987, 1: 1303-1306. 10.1016/S0140-6736(87)90552-6.CrossRefPubMed
21.
go back to reference De Quay N, Cerottini JP, Albe X, Saraga E, Givel JC, Caplin S: Prognosis in Dukes'B colorectal carcinoma: The Jass classification revisited. Eur J Surg. 1999, 165: 588-592. 10.1080/110241599750006514.CrossRefPubMed De Quay N, Cerottini JP, Albe X, Saraga E, Givel JC, Caplin S: Prognosis in Dukes'B colorectal carcinoma: The Jass classification revisited. Eur J Surg. 1999, 165: 588-592. 10.1080/110241599750006514.CrossRefPubMed
22.
go back to reference Abulafi AM, Williams NS: Local recurrence of colorectal cancer: the problems, mechanisms, management and adjuvant therapy. Br J Surg. 1994, 81: 7-19.CrossRefPubMed Abulafi AM, Williams NS: Local recurrence of colorectal cancer: the problems, mechanisms, management and adjuvant therapy. Br J Surg. 1994, 81: 7-19.CrossRefPubMed
23.
go back to reference Kapiteijn E, Klein Kranenbarg E, Steup WH, Taat CW, Rutten HJT, Wiggers T, et al: Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer - Prospective randomised trial with standard operative and histopathological techniques. Eur J Surg. 1999, 165: 410-420. 10.1080/110241599750006613.CrossRefPubMed Kapiteijn E, Klein Kranenbarg E, Steup WH, Taat CW, Rutten HJT, Wiggers T, et al: Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer - Prospective randomised trial with standard operative and histopathological techniques. Eur J Surg. 1999, 165: 410-420. 10.1080/110241599750006613.CrossRefPubMed
24.
go back to reference Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJH, van Krieken JHJM, Pathology Review Committee: Pathology data in the central database of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. J Clin Oncol. 2000, 18: 1771-1779.PubMed Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJH, van Krieken JHJM, Pathology Review Committee: Pathology data in the central database of multicenter randomized trials need to be based on pathology reports and controlled by trained quality managers. J Clin Oncol. 2000, 18: 1771-1779.PubMed
25.
go back to reference Tanooka H, Kitamura Y, Sado T, Tanaka K, Nagase M, Kondo S: Evidence for involvement of mast cells in tumor suppression in mice. J NatI Cancer Inst. 1982, 69: 1305-1309. Tanooka H, Kitamura Y, Sado T, Tanaka K, Nagase M, Kondo S: Evidence for involvement of mast cells in tumor suppression in mice. J NatI Cancer Inst. 1982, 69: 1305-1309.
26.
go back to reference Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al: Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996, 28: 543-548. 10.1046/j.1365-2559.1996.d01-467.x.CrossRefPubMed Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, et al: Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology. 1996, 28: 543-548. 10.1046/j.1365-2559.1996.d01-467.x.CrossRefPubMed
27.
go back to reference Das AM, Flower RJ, Perretti M: Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. Leukocyte Biol. 1998, 64: 156-162. Das AM, Flower RJ, Perretti M: Resident mast cells are important for eotaxin-induced eosinophil accumulation in vivo. Leukocyte Biol. 1998, 64: 156-162.
28.
go back to reference Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y: Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol. 1998, 160: 5554-5562.PubMed Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y: Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol. 1998, 160: 5554-5562.PubMed
29.
30.
go back to reference Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A, et al: Human eosinophils produce biologically active IL-12: Implications for control of T cell responses. J Immunol. 1998, 161: 415-420.PubMed Grewe M, Czech W, Morita A, Werfel T, Klammer M, Kapp A, et al: Human eosinophils produce biologically active IL-12: Implications for control of T cell responses. J Immunol. 1998, 161: 415-420.PubMed
31.
go back to reference Tartour E, Fridman WH: Cytokines and cancer. Intern Rev Immunol. 2000, 16: 683-704.CrossRef Tartour E, Fridman WH: Cytokines and cancer. Intern Rev Immunol. 2000, 16: 683-704.CrossRef
32.
go back to reference Pages F, Vives V, Sautes-Fridman C, Fossiez F, Berger A, Cugnenc PH, et al: Control of tumor development by intratumoral cytokines. Immunol Lett. 1999, 68: 135-139. 10.1016/S0165-2478(99)00042-5.CrossRefPubMed Pages F, Vives V, Sautes-Fridman C, Fossiez F, Berger A, Cugnenc PH, et al: Control of tumor development by intratumoral cytokines. Immunol Lett. 1999, 68: 135-139. 10.1016/S0165-2478(99)00042-5.CrossRefPubMed
33.
go back to reference Piancatelli D, Romano P, Sebastiani P, Adorno D, Casciani CU: Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunotherapy. 1999, 22: 25-32.CrossRef Piancatelli D, Romano P, Sebastiani P, Adorno D, Casciani CU: Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunotherapy. 1999, 22: 25-32.CrossRef
Metadata
Title
Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study
Authors
Iris D Nagtegaal
Corrie AM Marijnen
Elma Klein Kranenbarg
Adri Mulder-Stapel
Jo Hermans
Cornelis JH van de Velde
J Han JM van Krieken
Publication date
01-12-2001
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2001
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-1-7

Other articles of this Issue 1/2001

BMC Cancer 1/2001 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine